Close this search box.

How-To Guides

Get access to our exclusively curated how-to guides to help you navigate through the world of cybersecurity and its adversaries.

Lyell Immunopharma Improves Cloud Security with Fidelis Security

Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.

Filter by Product:

  • Securing Hybrid Cloud Environments with Fidelis Halo

    Discover how to secure hybrid cloud deployments, bridging cloud and...

    Read How To
  • Securing Greenfield Cloud Applications with Fidelis Halo

    Learn to secure cloud-native applications with ease. Explore architecture, automation,...

    Read How To
  • Guide to Secure your Kubernetes Environments

    Learn to automate security controls in Kubernetes environments. Get insights...

    Read How To
  • Network DLP Solution: Key Features & Considerations

    Navigate the network DLP challenge effectively. Learn about key features...

    Read How To
  • Ensuring Secure Lift-and-Shift Cloud Migrations with Fidelis CNAPP Solution

    Discover how to ensure a secure transition to cloud environments....

    Read How To
  • Fidelis Security

    How to Implement Deception Technologies?

    It is often stated that “defenders need to be right...

    Read How To